Iradimed Corp (IRMD) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Iradimed reported revenue of $83.8M, up 14.4% from $73.2M the year before. Net income was $22.5M (a 26.8% net margin), or $1.75 per diluted share. Gross margin was 76.7% and operating margin was 31.2%. Operating activities generated $24.9M of cash, leaving $17.2M of free cash flow. At fiscal year end, Iradimed held $108.8M in total assets against $14.2M in total liabilities, including $51.2M of cash and equivalents.
Open the full interactive Iradimed financials → Quarterly statements, key ratios, valuation history and price charts.
Iradimed Key Stats
| Share Price | $89.65 |
|---|---|
| Market Cap | $1.15B |
| P/E Ratio | 51.2 |
| Dividend Yield | 1.37% |
| Revenue YoY Growth | +14.4% |
| 52-Week Range | $71.42 – $104.63 |
| Shares Outstanding | 12.8 million (basic, 2026 Q2) |
Iradimed Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $31.7M | $41.8M | $53.3M | $65.6M | $73.2M | $83.8M |
| Gross Profit | $23.6M | $32.0M | $41.3M | $50.2M | $56.3M | $64.3M |
| Operating Income | -$756,091 | $9.8M | $15.6M | $20.0M | $22.0M | $26.1M |
| Pre-Tax Income | -$616,878 | $9.8M | $16.2M | $21.7M | $24.3M | $28.4M |
| Income Tax | -$2.0M | $510,816 | $3.4M | $4.5M | $5.0M | $5.9M |
| Net Income | $1.4M | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M |
| Diluted EPS | $0.11 | $0.74 | $1.02 | $1.35 | $1.50 | $1.75 |
Iradimed Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $21.2M | $22.7M | $22.0M | $20.5M |
| Net Income | $5.6M | $6.4M | $5.8M | $5.2M |
| Diluted EPS | $0.43 | $0.50 | $0.45 | $0.41 |
Iradimed Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $50.1M | $62.0M | $58.0M | $49.8M | $52.2M | $51.2M |
| Current Assets | $63.7M | $76.2M | $77.5M | $76.0M | $75.2M | $81.2M |
| Total Assets | $71.1M | $82.9M | $85.5M | $92.2M | $98.3M | $108.8M |
| Current Liabilities | $4.9M | $6.8M | $8.6M | $16.3M | $8.5M | $10.2M |
| Total Liabilities | $9.7M | $10.7M | $11.8M | $20.7M | $11.5M | $14.2M |
| Shareholders' Equity | $61.4M | $72.2M | $73.7M | $71.4M | $86.8M | $94.6M |
Iradimed Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $5.8M | $11.3M | $10.0M | $13.5M | $25.6M | $24.9M |
| Cash From Investing | $246,969 | $648,241 | -$1.4M | -$8.0M | -$8.8M | -$8.4M |
| Cash From Financing | $522,482 | $24,425 | -$12.7M | -$13.7M | -$14.3M | -$17.6M |
| Free Cash Flow | $5.4M | $10.8M | $9.2M | $6.0M | $17.6M | $17.2M |
| Dividends Paid | — | — | $12.6M | $13.2M | $13.7M | $15.0M |
Figures from Iradimed's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Iradimed financials page for every line item.
Iradimed Company Profile
| Ticker | IRMD |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Orlando, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001325618 |
Frequently Asked Questions
What was Iradimed's revenue in fiscal 2025?
Iradimed (IRMD) reported revenue of $83.8M for fiscal 2025.
What is Iradimed's annual revenue history?
Iradimed's annual revenue by fiscal year: 2020: $31.7M; 2021: $41.8M; 2022: $53.3M; 2023: $65.6M; 2024: $73.2M; 2025: $83.8M.
What was Iradimed's net income in fiscal 2025?
Iradimed reported net income of $22.5M for fiscal 2025.
What was Iradimed's earnings per share (EPS) in fiscal 2025?
Iradimed's diluted EPS was $1.75 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Iradimed generate in fiscal 2025?
Iradimed generated $17.2M of free cash flow in fiscal 2025.
What was Iradimed's revenue last quarter?
In its most recent reported quarter (2026 Q2), Iradimed reported revenue of $20.5M.
How many shares of Iradimed are outstanding?
Iradimed reported a weighted average of 12.8 million basic shares outstanding in 2026 Q2.
What is Iradimed's market cap?
Based on its latest closing price, Iradimed (IRMD) has a market capitalization of about $1.15B.
When does Iradimed's fiscal year end?
Iradimed's fiscal year end, as registered with the SEC, is December 31.
Where is Iradimed headquartered?
Iradimed lists its business address in Orlando, Florida in its SEC filings.
Iradimed Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →